Purging and haemopoietic progenitor cell selection by CD34+ cell separation

Area of Science:

• Hematology
• Cancer Biology
• Cell Therapy

Background:

• Autologous stem cell transplantation, using peripheral blood stem cells (PBSC) or bone marrow (BM), is frequently complicated by tumour cell contamination.
• Enrichment of CD34+ stem cells is a key strategy for purging contaminating tumour cells from autografts while preserving progenitor cells.

Purpose of the Study:

• To evaluate the efficacy of different CD34+ cell enrichment methods in purging tumour cells from PBSC and BM harvests.
• To compare the purity, recovery, and tumour cell reduction capabilities of immunomagnetic separation versus immunoaffinity column-based techniques.

Main Methods:

• Breast cancer cells were spiked into mononuclear cells from PBSC and BM harvests.
• CD34+ cells were enriched using immunomagnetic separation (Isolex-50, MiniMACS) and biotin-streptavidin immunoaffinity columns (Ceprate-LC).
• Purity and recovery of CD34+ cells were assessed by FACS, and tumour cell contamination was quantified using immunocytochemistry.

Main Results:

• Immunomagnetic separation (MiniMACS) yielded significantly higher CD34+ cell purity (median 96.5%) compared to other methods.
• Tumour cell purging was significantly superior with immunomagnetic separation (median log reduction 3.5-3.7) compared to immunoaffinity (median log reduction 1.5).
• Recovery rates of CD34+ cells varied significantly across all tested devices.

Conclusions:

• Immunomagnetic separation is a more efficient method for purging contaminating tumour cells from autologous stem cell collections than immunoaffinity techniques.
• CD34+ selection using immunomagnetic separation enhances the safety of autografts by reducing the risk of tumour cell reinfusion.
• Further studies are needed to confirm these findings with fresh contaminating tumour cells.